Page last updated: 2024-08-23

bromocriptine and pasireotide

bromocriptine has been researched along with pasireotide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Mezosi, E; Nemes, O1
Góth, M1
Colwell, HH; Fleseriu, M; Fogelfeld, L; Gordon, MB; Haviv, A; Ludlam, WH; Mathias, SD; Sisco, J1
Kawakami, K; Matsubayashi, K1

Reviews

2 review(s) available for bromocriptine and pasireotide

ArticleYear
[Treatment of pituitary adenomas].
    Orvosi hetilap, 2009, Sep-27, Volume: 150, Issue:39

    Topics: Acromegaly; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Aminoquinolines; Bromocriptine; Cushing Syndrome; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hypophysectomy; Incidental Findings; Male; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Radiosurgery; Receptors, Somatotropin; Somatostatin; Thyrotropin

2009
[Drug therapy for acromegaly].
    Orvosi hetilap, 2013, Sep-29, Volume: 154, Issue:39

    Topics: Acromegaly; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Interdisciplinary Communication; Membrane Proteins; Octreotide; Patient Care Team; Peptides, Cyclic; Pituitary Neoplasms; Somatostatin

2013

Other Studies

2 other study(ies) available for bromocriptine and pasireotide

ArticleYear
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ.
    Pituitary, 2019, Volume: 22, Issue:6

    Topics: Acromegaly; Adult; Bromocriptine; Cabergoline; Female; Human Growth Hormone; Humans; Interviews as Topic; Male; Middle Aged; Octreotide; Peptides, Cyclic; Personal Satisfaction; Somatostatin; Surveys and Questionnaires

2019
Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database.
    Endocrine journal, 2020, Oct-28, Volume: 67, Issue:10

    Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Comorbidity; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hyperlipidemias; Hypertension; Incidence; Japan; Male; Middle Aged; Neurosurgical Procedures; Octreotide; Peptides, Cyclic; Prevalence; Radiosurgery; Radiotherapy, Intensity-Modulated; Retrospective Studies; Somatostatin; Young Adult

2020